Skip to content

Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1

Evaluation of a Desipramine Ceiling in Cocaine Abuse

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000245
Enrollment
0
Registered
1999-09-21
Start date
1994-05-31
Completion date
2001-12-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Substance-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to confirm whether a blood level ceiling exists on desipramine effect in cocaine abuse.

Interventions

DRUGDesipramine

Sponsors

Friends Research Institute, Inc.
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Craving
Retention
Cocaine use
Depression
Anxiety
Mood indicators

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026